ROS1-Rearranged Lung Adenocarcinoma: From Molecular Genetics to Target Therapy
Non-small-cell lung cancer (NSCLC) is a heterogeneous group of diseases accounting for 80–85% of lung cancers. A molecular subset of NSCLC (1–2.5%) harboring molecular rearrangements of the tyrosine kinase gene <i>ROS1</i> is defined as ROS1-positive and is almost exclusively diagnosed i...
| Үндсэн зохиолчид: | , , |
|---|---|
| Формат: | Өгүүллэг |
| Хэл сонгох: | English |
| Хэвлэсэн: |
MDPI AG
2023-08-01
|
| Цуврал: | Onco |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://www.mdpi.com/2673-7523/3/3/14 |